Inmune Bio, Inc. — Institutional Ownership
Which tracked institutions hold INMB, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
13
Funds holding
$2628397
Total value held
Buying
8 added/new · 5 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $1349347 | 1194112 | -17988 | -1.48% |
| 2 | State Street Corp | $328693 | 290879 | -56380 | -16.24% |
| 3 | Goldman Sachs Group Inc | $261692 | 231586 | +175109 | +310.05% |
| 4 | Raymond James Financial Inc | $229667 | 203245 | -7433 | -3.53% |
| 5 | Northern Trust Corp | $208174 | 184225 | +8576 | +4.88% |
| 6 | Bank Of New York Mellon Corp | $60599 | 53628 | -4893 | -8.36% |
| 7 | Morgan Stanley | $50411 | 44611 | -77901 | -63.59% |
| 8 | Pnc Financial Services Group, Inc. | $45336 | 40120 | +2315 | +6.12% |
| 9 | Wells Fargo & Company/Mn | $38777 | 24857 | +10970 | +78.99% |
| 10 | Bank Of America Corp /De/ | $28818 | 25502 | +6961 | +37.54% |
| 11 | Barclays Plc | $21070 | 18646 | — | NEW BUY |
| 12 | Royal Bank Of Canada | $3000 | 2684 | — | NEW BUY |
| 13 | Citigroup Inc | $2813 | 1803 | +918 | +103.73% |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.